2023
DOI: 10.1016/j.nbas.2022.100062
|View full text |Cite
|
Sign up to set email alerts
|

Age-related reduction in brain ACE-2 is not exacerbated by Alzheimer’s disease pathology in mouse models of Alzheimer’s disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 55 publications
0
1
0
Order By: Relevance
“…The RADAR Trial, a double-blind, randomized, placebo-controlled, phase 2 trial concluded that 12 months' treatment with losartan (an AT1R Ang II receptor blocker) was not effective in reducing the rate of brain atrophy in Alzheimer's patients [65]. In mouse models of Alzheimer's disease, the reduction in ACE2 levels and activity and increased Ang II did not exacerbate Alzheimer's disease pathology [66]. Furthermore, while it is widely thought that AT1R mediates the pathogenesis of Alzheimer's disease [67], Ang II can activate AT1R and AT2R, which could exert opposite biological effects.…”
Section: Alternative To the Stated Hypothesismentioning
confidence: 99%
“…The RADAR Trial, a double-blind, randomized, placebo-controlled, phase 2 trial concluded that 12 months' treatment with losartan (an AT1R Ang II receptor blocker) was not effective in reducing the rate of brain atrophy in Alzheimer's patients [65]. In mouse models of Alzheimer's disease, the reduction in ACE2 levels and activity and increased Ang II did not exacerbate Alzheimer's disease pathology [66]. Furthermore, while it is widely thought that AT1R mediates the pathogenesis of Alzheimer's disease [67], Ang II can activate AT1R and AT2R, which could exert opposite biological effects.…”
Section: Alternative To the Stated Hypothesismentioning
confidence: 99%
“…Renin-angiotensin system (RAS) has two major axes. The classical axis ACE/Ang II/angiotensin II type 1 receptor (AT1R), and the counter-regulatory axes ACE-2/Angiotensin 1–7 (Ang 1–7) Mas receptor (MasR) and ACE2/Ang 1–9/AT2R ( Sepulveda-Fragoso et al, 2021 ; MacLachlan et al, 2023 ). The Mas axis was identified recently as a factor involved in macrophage function during inflammatory processes in vascular and central nervous systems ( Hammer et al, 2016 ).…”
Section: Introductionmentioning
confidence: 99%